Clinical Trials Logo

Clinical Trial Summary

Obesity is a prevalent, destructive, and costly chronic disease. In 2008, 37% of Canadian adults were measured as overweight, and 25% as obese. Obesity is a risk factor for a number of serious health problems, including type 2 diabetes, asthma, gallbladder disease, osteoarthritis, chronic back pain, several types of cancers (i.e., colorectal, kidney, breast, endometrial, ovarian and pancreatic cancers) and cardiovascular disease (i.e., hypertension, stroke, congestive heart failure and coronary artery disease). In 2008, it was estimated that the annual economic burden of obesity in Canada was $4.6 billion. Given the economic strain and widespread health risks of obesity, there is a clear need to provide effective interventions for obesity. The purpose of the proposed study is to examine the role of ACT-based interventions in long-term weight maintenance. The proposed study will examine the role of value consistent behaviour, acceptance skills, and mindfulness skills in promoting long-term weight-related health behaviours. Acceptance and Commitment Therapy (ACT) is an empirically supported psychological intervention that emphasizes value consistent behaviours, acceptance skills and mindfulness skills.


Clinical Trial Description

Participants will be recruited from the weight loss surgery waitlist and randomly assigned to a brief (5 sessions) ACT intervention or to waitlist control group. A mobile app will be used to encourage daily ACT skill practice and track health behaviours over time. The primary objective of the proposed project is to test whether a brief ACT intervention can result in sustained weight management (at 6 months and 1 year) compared to a waitlist control group. If this brief format of ACT intervention for obesity proves to be effective in encouraging health behaviours and weight loss, it may provide a low cost, sustainable option to enhance much needed obesity management services in Nova Scotia. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02749552
Study type Interventional
Source Nova Scotia Health Authority
Contact
Status Completed
Phase N/A
Start date January 21, 2021
Completion date October 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2